Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Doctors Frustrated By Lack Of Guidance On Who Should Get Aduhelm
Broad Label Has No Requirement To Test For Amyloid
Jun 12 2021
•
By
Mandy Jackson
Pivotal trials tested Aduhelm in patients with early Alzheimer's disease and mild cognitive impairment • Source: Alamy
More from Neurological
More from Therapeutic Category